Literature Search, SOTA Review process and Clinical Evaluation

Sandra Gopinath
Literature Search, SOTA Review and Clinical Evaluation

A literature search & review is a vital component of the Clinical Evaluation of medical devices. It is also challenging to perform and is an aspect of Clinical Evaluation that can be a source of confusion, difficulty and non-conformity.

In this article, we help to demystify the process of systematic review of literature for Clinical Evaluation.

What is MedDev 2.7/1 rev 4?

MedDev 2.7/1 rev 4 is one of a series of guidance documents published by the European Commission intended to assist medical device manufacturers and Notified Bodies in meeting medical device regulatory obligations. MedDev stands for MEDical DEVices documents. MedDev 2.7/1 rev 4 is a detailed document which sets out comprehensive guidelines for medical device manufacturers and notified bodies for the conduct of Clinical Evaluation. MedDev 2.7/1 rev 4 is a technical document which can be challenging to digest.

Appendix 5 of the MedDev guideline sets out requirements for the identification and review of literature in the context of Clinical Evaluation. It is therefore central to performing a compliant literature review.

What is the role of a literature review in medical device Clinical Evaluation?

The review of published literature is a critical component of medical device Clinical Evaluation. A literature review is performed to inform two major elements of a Clinical Evaluation:

  • A review of the current knowledge/ the state of the art (SOTA) – this enables the identification of safety and performance benchmarks against which performance of the subject (and, if relevant, equivalent) device may be evaluated
  • A review of literature relating to the subject (and equivalent) device.

It is a requirement that literature searches are performed according to a documented protocol and that they include both favourable and unfavourable data. They must be representative and not be biased or selective; therefore, methods must be set out clearly for inclusion, exclusion, appraisal and analysis of sources.

What guidance is offered by MedDev 2.7/1 rev 4 Appendix 5?

Appendix 5 of MedDev 2.7/1 rev 4 provides a range of guidance for Clinical Evaluation literature searches & reviews, including:

  • Offering general instructions on literature searching
  • Outlining methods for constructing protocols for undertaking a literature review
  • Defining the key elements of literature reviews that are required in order to deliver a compliant Clinical Evaluation Report.

Understanding the literature search & review process explained in Appendix 5 can be made easier by dividing it into four stages:

  • Stage 1 Background

    1. Search criteria
    2. Databases
    3. Inclusion & exclusion criteria
  • Stage 2 Literature Screen

    1. Analysing abstracts
    2. Full article
  • Stage 3 Appraisal & Analysis

    1. Selection & Exclusion
    2. Critique & Appraise
    3. Analysis
  • Stage 4 Literature Report

    1. Benefits / Risk
    2. Conclusion
    3. Report

Background to the literature search stage sets the scene for the substantive literature search, review, appraisal and report to follow. Performed properly, a rationale for performing the literature review should be clearly documented.

The background to the literature search should include information such as:

  1. Name of the device/model.
  2. Importance of literature review in the risk management process. The review should provide data on current therapies, diagnostic measures, and measures for the management of medical conditions for the targeted patient population. This will help in order to assess the acceptable benefits/risks.
  3. Outcomes of previous literature reviews and literature searches conducted by manufacturer.
  4. Identification of any equivalent or benchmark devices to be included in the evaluation, including the name and model of these devices.

Carefully formulated research question(s) should be set out to guide the selection of search terms. Selected search terms will then be subjected to an objective, non-biased, systematic search and review. The inputs required for this section are the device description and the expected device performance; these can be applied for the formation of relevant research questions. Methods or protocols adopted for the conduct of literature review should set out the search methodology, sources of data, selection & exclusion criteria and appraisal/critique methodology.

Stage 2: Literature Screen

The next step is to screen initial results for relevance to the research questions. This stage can be thought of as a ‘triage’ of sources, with the objective being to limit full appraisal to only those results that are pertinent.

MedDev 2.7/1 rev 4 requires the use of carefully formulated inclusion / exclusion criteria, augmented by an objective, non-biased, systematic screening and review process such as PICO (patient characteristics, type of intervention, control, and outcome queries), or PRISMA (The Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Whatever method is used, it should align with the method specified in the search protocol (or review protocol) developed prior to commencing the review.

In a practical sense, begin by reviewing the titles and abstracts – the full text is not required at this stage. Due to the number of results often found by search terms, screening needs to be efficient while maintaining appropriate scrutiny. It may be helpful to use exclusion codes to codify reasons for exclusions (which may include, for example, “unrelated topic” or “article not available in English” etc).

Remember — this stage is all about identifying relevant sources.

Stage 3: Appraisal & Analysis

Before considering how to perform appraisal and analysis, it’s important to understand the difference between them:

  • Appraisal means to assess the quality of a source, methodological quality, scientific validity, reliability, relevance and weighting to the evaluation.
  • Analysis is the post-appraisal stage of evaluating what the results mean (or what they tell us). Appraisal and weighting should be considered during analysis.

According to MedDev 2.7/1 rev 4, an appraisal plan should form part of the search protocol. It is advisable to create an appraisal framework covering multiple domains (such as relevance, clinical significance, study type, etc) and it can be useful to assign a code to each appraisal element. As part of appraisal, a score can be applied against each appraisal domain, forming a structured and codified appraisal summary of each source and the ‘body’ of sources as a whole.

Weighting is a key concept in appraisal that’s worth considering independently. The weighting of a source indicates how much importance should be placed on the results of that source when compared to others. A high weighting indicates that the results should be deemed more relevant to the evaluation than data from a lower weighting source.

Following appraisal, the next stage is to analyse the data. The analysis will depend on the reason for conducting the literature review; in a clinical evaluation, the appraisal may consider (for example):

  1. Does the data demonstrate that the device is suitable for its intended purpose?
  2. Does the data demonstrate compliance with the relevant General Safety and Performance Requirements (GSPRs)?

During appraisal, ensure that an objective approach is taken and that both favourable and unfavourable data is treated equally.

Stage 4: Literature Review Report

The fourth and final stage of the literature analysis and review process is preparing a literature review report. While writing the report, especially if performed in the context of a clinical evaluation, it is important to identify quantifiable safety and performance parameters, whether in relation to the subject device or comparable alternatives.

Ensure the report includes enough information for a reviewer to understand how the search was conducted and what appraisal and analysis criteria were used. Present a summary of each source (outlining a rationale for the appraisal and weighting) in the body of the document and outline the analysis towards the end.

The bottom line

Performing a systematic literature review to the required standard is not easy. While the framework in Appendix 5 of MedDev 2.7/1 rev 4 is not without its limitations, it is useful as a starting point and in ensuring that the review has an appropriate structure without major omissions.

At Mantra Systems, our team of medical experts are on hand to support your literature search & review requirements. If you need any information or advice, please contact us for a free discussion.

Note: A shortened version of this article was previously published on 20th October, 2021.

Related articles

  1. EU flags

    Regulation (EU) 2024/1860 - Its impact on EU MDR and IVDR

    How does the recent Regulation (EU) 2024/1860 amendment affect the EU MDR & IVDR?

    Shona Richardson Shona Richardson Regulatory Medical Writer
  2. EU flag

    MDCG 2024-10 - Orphan medical devices

    How to apply MDR pre-market clinical evidence requirements to medical devices intended for limited usage.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  3. Considering a medical device's intended purpose

    A medical device's intended purpose - what is the point?

    How do you define intended purpose, indication for use, intended clinical benefits, and claims?

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  4. Mantra Systems presents EnableChat, your AI-powered MDR & MDCG chatbot

    EnableChat - Your AI-powered MDR and MDCG chatbot

    Search the MDR and MDCG documents in seconds by asking EnableChat your questions.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  5. Searching adverse event databases for vigilance data

    Staying vigilant - A guide to searching for adverse events data

    We discuss the pros and cons of existing adverse event databases for vigilance data searching.

    Dr Simon Cumiskey Dr Simon Cumiskey Senior Lead Medical Writer
  6. A doctor reading an SSCP document with a patient

    What is Summary of Safety and Clinical Performance (SSCP)?

    We explain what the SSCP is, when you'll need it and what its objectives are.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  7. A pile of question marks

    Medical Device 'Significant Changes' – Navigating EU MDR Article 120(3) using MDCG 2020-3 rev. 1

    Understand what changes to your medical device are considered 'significant' under EU MDR (2017/745).

    Shen May Khoo Shen May Khoo Junior Regulatory Specialist
  8. A signpost giving unsure directions

    MDR or IVDR - A sibling rivalry?

    A guide to easily understanding whether your device is a medical device or an in vitro diagnostic medical device (IVD).

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. An EU and UK flag

    What the latest Brexit U-turn means for CE Marking of medical devices in Great Britain

    Will Great Britain continue to allow the use of the CE mark for medical devices beyond the 2024 deadline?

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  10. A woman writing her own medical device regulation documentation

    Gain confidence, reassurance and control over your EU MDR strategy

    Find out how to build your own technical files within a guided framework while minimising financial outlays.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  11. Racing to achieve MDR compliance

    Still racing to achieve MDR compliance? A transition period update

    On January 6th 2023, the EU commission has adopted the proposal to extend the transition rules of the EU MDR.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  12. A 7-step guide to navigating regulatory requirements for medical device start-ups

    A medical device regulations guide for start-up companies

    We present a 7-step guide to navigating regulatory requirements on a budget.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  13. An update on UKCA Marking of Medical Devices

    UKCA Marking of Medical Devices – An update on the status quo

    We review recently updated requirements for UKCA marking and what it means for your regulatory strategy.

    Dr Hanna Gul Dr Hanna Gul Lead Medical Writer
  14. How to choose a CER writer for your MDR Clinical Evaluation

    Choosing a CER writer for your MDR Clinical Evaluations

    We've compiled a list of considerations that will help you make the right choice when choosing a CER writer.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  15. Achieving MDR Compliance for Class I medical devices

    How to achieve MDR Compliance for Class I medical devices

    We outline a strategy for the regulatory compliance of Class I medical devices.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  16. Literature Search Protocols & SOTA Reviews for medical devices and what to know before you start

    Literature searches and reviews for medical devices - what to know before you start

    We explain what you should know before beginning a literature search & review for your medical device.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  17. Five useful resources when writing a medical device CER

    Five useful resources when writing a medical device CER

    We outline five of the most useful and trustworthy Clinical Evaluation Report writing resources.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  18. Avoid pitfalls when writing a Clinical Evaluation Report

    Five common pitfalls when writing a Clinical Evaluation Report

    We illustrate five pitfalls when writing CERs and give you some tips to overcome them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  19. How to make a medical device equivalence claim under the MDR

    Five tips for making a medical device equivalence claim under the MDR

    We'll show you what to keep in mind with regards to equivalance and Clinical Evaluation.

    Sandra Gopinath Sandra Gopinath Chief Regulatory Officer
  20. Keeping medical devices in market and maintaining CE-marks - a guide to effective data collection

    Keeping medical devices in market and maintaining CE-marks

    The 4 golden rules to drive regulatory compliance with PMCF and vigilance data collection.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  21. How PMCF goes beyond simple compliance - improving products and engaging customers

    How PMCF goes beyond simple compliance

    The wider benefits of a well-designed PMCF system include improving your products and your relationship with your clients.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  22. PMCF systems for medical devices

    Why you'll almost certainly need a PMCF system for your medical devices

    We tell you what to be aware of under the EU MDR regarding PMCF and your medical devices.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  23. Ensure medical device regulatory compliance of your devices through Brexit

    The impact of Brexit on medical device regulatory compliance

    How to ensure regulatory alignment of your devices in the territories affected by Brexit.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  24. Use medical device regulatory consulting services to supercharge your MDR transition

    Is outside consulting support the answer to your MDR transition?

    Getting ready for the MDR is a demanding process. Outsourcing might be your solution.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  25. Increasing data entry compliance in PMCF studies

    Increasing data entry compliance in PMCF studies

    5 methods every medical device manufacturer should know to improve their Post-Market Clinical Follow-up studies.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  26. Why medical doctors can drive MDR compliance

    Why medical doctors can drive MDR compliance

    Working with the MDR requires knowing how to work with clinical evidence. Medical doctors are perfectly positioned to meet this requirement.

    Dr Victoria Cartwright Dr Victoria Cartwright Relationship Manager
  27. Software as a Medical Device

    Software as a Medical Device

    Unless you have spent time working with medical device legislation in the past, the idea that software could be a medical device may be rather unexpected.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  28. clinical investigator for pmcf eu mdr compliance

    Ensuring that clinical investigations work in practice

    How can medical device manufacturers ensure valid clinical investigations when access to medical expertise remains limited?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  29. Coronavirus and medical device regulations

    Relaxing medical device regulatory requirements during a healthcare crisis

    During the coronavirus pandemic, how far should we go when relaxing medical device regulatory requirements?

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  30. The new MDR compliance challenge

    The new MDR compliance challenge

    Across the industry, medical device companies are facing challenges in meeting the demands of the new Medical Device Regulations (MDR) 2017/745 framework.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer
  31. Sources of Real World Evidence for MDR compliance

    Sources of Real World Evidence for MDR compliance

    At Mantra Systems our objective is to make sure that our clients choose the method of real world data harvesting that is right for them.

    Dr Paul Hercock Dr Paul Hercock Chief Executive Officer

More articles

Do you need support with your medical device approval strategy?

Enquire today

Close

Let's talk

Send an enquiry or book a free discovery meeting to see how we can support your market access strategy